Cargando…
Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis
Immune checkpoint inhibitors (ICI) have become the standard of care treatment for several tumor types. ICI-induced pneumonitis is a serious complication seen with treatment with these agents. Cancer has been reported to be one of the risk factors for severe coronavirus disease 2019 (COVID-19) caused...
Autores principales: | Dumoulin, Daphne W., Gietema, Hester A., Paats, Marthe S., Hendriks, Lizza E. L., Cornelissen, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658907/ https://www.ncbi.nlm.nih.gov/pubmed/33194697 http://dx.doi.org/10.3389/fonc.2020.577696 |
Ejemplares similares
-
Common methodological pitfalls in ICI pneumonitis risk prediction studies
por: Chen, Yichen K., et al.
Publicado: (2023) -
Trastuzumab-Induced Interstitial Pneumonitis
por: Errisuriz, Kimberly, et al.
Publicado: (2023) -
Infliximab-Induced Interstitial Pneumonitis: A Case Report
por: Makkawy, Eyad A, et al.
Publicado: (2023) -
Palbociclib-Induced Pneumonitis: A Case Report and Review of the Literature
por: Sarkisian, Saro, et al.
Publicado: (2020) -
Azacitidine-Induced Pneumonitis in a Patient With Acute Myeloid Leukemia and Hyperleukocytosis
por: Litvin, Rafaella, et al.
Publicado: (2022)